Immature platelets in patients with acute coronary syndromes
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Summary: Platelets newly released from the bone marrow are RNA-containing and more haemostatically active than mature platelets. Immature platelets are reliably quantified by flow cytometry, and the immature platelet fraction (IPF) reflects platelet production and the rate of platelet turnover. It was the objective of this study to evaluate the presence of immature platelets in healthy subjects, patients with stable coronary artery disease (CAD) and patients with acute coronary syndromes. Flow cytometric determination of immature platelets was performed with an automated analyzer (Sysmex XE-2100) using RNA fluorescent dyes. IPF was determined in 420 individuals: 22 healthy subjects, 39 patients with stable CAD, 182 patients with unstable angina/ non-ST-segment elevation myocardial infarction (non-STEMI) and 177 patients with acute STEMI. The geometric mean [95% confidence interval] of IPF was 2.51 [2.04–3.10] in healthy subjects, 2.87 [2.45–3.36] in CAD patients, 2.93 [2.72–3.15] in the non-STEMI/unstable angina group and 3.71 [3.45–3.99] in patients with STEMI (ANOVA: p < 0.0001). This difference remained significant after adjusting for baseline characteristics (p = 0.0003). In active smokers, IPF was 18% higher than in non-smoking individuals (p = 0.007), and IPF was 16% higher in diabetics compared with non-diabetics (p = 0.060). In conclusion, the fraction of immature platelets is increased in acute coronary syndromes, especially in the acute phase of STEMI. Immature platelets with an increased haemostatic potential may contribute to coronary thrombus formation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased platelet clearance results in a reduced platelet life span and a relative preponderance of large, immature circulating platelets.34,35”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [35]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos, G., Brister, S. J., Beattie, W. S., & Buchanan, M. R. (2008) · BMJ · doi:10.1136/bmj.39430.529549.be · Cited by 708
Martin, J. F., Trowbridge, E. A., Salmon, G., & Plumb, J. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90255-4 · Cited by 466
Snoep, J. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1593 · Cited by 412
Thompson, C. B., Eaton, K. A., Princiotta, S. M., Rushin, C. A., & Valeri, C. R. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb01947.x · Cited by 375
Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia
Briggs, C., Kunka, S., Hart, D., Oguni, S., & Machin, S. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04987.x · Cited by 354
Ault, K. A., Rinder, H. M., Mitchell, J., Carmody, M. B., Vary, C. P. H., & Hillman, R. S. (1992) · American Journal of Clinical Pathology · doi:10.1093/ajcp/98.6.637 · Cited by 260
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
Maree, A. O., & Fitzgerald, D. J. (2007) · Circulation · doi:10.1161/circulationaha.106.675991 · Cited by 211
Changes in volume and density of platelets in myocardial infarction.
Martin, J. F., Plumb, J., Kilbey, R. S., & Kishk, Y. T. (1983) · BMJ · doi:10.1136/bmj.287.6390.456 · Cited by 201
Determinants of the interindividual variability in response to antiplatelet drugs
Rocca, B., & Patrono, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01380.x · Cited by 89
Cited by
Items 201–202 of 202
Asher, E., Taha, L., Karmi, M., Sabouret, P. F., Mamas, M. A., Atar, D., Fink, N., Naimark, A., Glikson, M., & Intervention in Cardiology (JUPITER-27) Study Group on behalf of the Jerusalem Platelets Thrombosis (2026) · Thrombosis and Haemostasis · doi:10.1055/a-2945-5355
Grignano, M. A., Gregorini, M., Stea, E. D., Pattonieri, E. F., Soccio, G., Gentile, R., Albertini, R., Ciardelli, L. M., Russo, E., Rampino, T., et al. (2026) · Renal Replacement Therapy · doi:10.1186/s41100-026-00779-z
“…protein-synthesis capacity and have been associated with reduced pharmacodynamic response to aspirin or clopidogrel in cardiovascular cohorts [7, 8, 29], our study did not include platelet-function testing and therefore cannot determine whether the post-HD rise in IPF compromises antiplatelet…”
Metadata
- Authors
- Hvas, A.-M., Kristensen, S. D., & Grove, E. L.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Grove, Erik Lerkevang
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2009
- Volume
- 101
- Issue
- 01
- Pages
- 151-153
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2127436599
- Cited by
- 202
- References
- 14
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 16 · 2022: 7 · 2021: 11 · 2020: 12 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 11 · 2015: 16 · 2014: 14 · 2013: 10 · 2012: 17
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Danish Research Agency (2101–05–0052 to ELG and SDK)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- immature platelets, immature platelet fraction, acute coronary syndrome, stable coronary artery disease, acute myocardial infarction, unstable angina, platelet turnover, megakaryopoiesis, smoking, diabetes mellitus, coronary thrombus formation, hemostatic activity
- MeSH terms
- Adult, Aged, Aged, 80 and over, Angina, Unstable, Blood Platelets, Coronary Artery Disease, Coronary Thrombosis, Female, Flow Cytometry, Hemostasis, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Count, Risk Factors, Linear Models, Case-Control Studies, Risk Assessment, Thrombopoiesis, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.